Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BAS: Glargine and Detemir vs NPH in New-Onset T1DM Adolescents
NCT01271517Phase 4Unknown
- Sponsor
- Karolinska Institutet
- Start
- Sep 2005
- Primary completion
- Mar 2011
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of insulin glargine, insulin detemir in type 1 diabetes mellitus (T1D), sponsored by Karolinska Institutet. Status: unknown.
02
Drugs
insulin glargineinsulin detemir
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT01271517.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01271517.